Five new mononuclear complexes of 2-(5-methyl-1H-pyrazol-3-yl)pyridine: Synthesis, crystalline architectures through supramolecular interactions and spectroscopy was written by Zhu, Guang-Zhou;Xing, Bei-Bei;Yang, Feng-Lei;Li, Xiu-Ling. And the article was included in Polyhedron in 2014.Recommanded Product: 19959-77-4 This article mentions the following:
Five new mononuclear complexes with 2-(5-methyl-1H-pyrazol-3-yl)pyridine (L) were synthesized, namely [ZnLCl2] (1), [NiL2(H2O)2]Cl2·0.5N2H4 (2), [MnL2Cl2]·3H2O (3), [CdL2(NO3)2] (4) and [MnL2(Pa)2] (5, Pa = m-phthalic acid). All these compounds were characterized by elemental anal., IR and UV-visible spectroscopy, and x-ray single crystal diffraction. The crystal structures reveal that compounds 2, 3 and 5 afford six-coordinated octahedral spheres, while compound 1 displays a four-coordinated tetrahedral core and compound 4 forms an eight-coordinated geometry. Furthermore, the 3D supramol. networks, formed through plentiful H-bonds and weak mol. interactions, were analyzed. The photoluminescent properties of the ligand L, together with compounds 1 and 4, were also studied in methanol solution at room temperature In the experiment, the researchers used many compounds, for example, 2-(5-Methyl-1H-pyrazol-3-yl)pyridine (cas: 19959-77-4Recommanded Product: 19959-77-4).
2-(5-Methyl-1H-pyrazol-3-yl)pyridine (cas: 19959-77-4) belongs to pyrazole derivatives. The strategies for the synthesis of pyrazoles generally can be applied for the construction of indazoles. Pyrazole rings have been used as core components of several leading non-steroidal anti-inflammatory drugs (NSAIDs) and antihypertensive drugs. It has also been found to be useful as a bifunctional ligand for metal catalysis.Recommanded Product: 19959-77-4
Referemce:
Pyrazole – Wikipedia,
Pyrazoles – an overview | ScienceDirect Topics